VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC

Merger with Notable expected to close in mid-October, subject to shareholder approval

Special shareholder meeting scheduled for October 12, 2023

Read more at globenewswire.com